Abstract
BackgroundTocilizumab (T) is a new biological agent for the treatment of rheumatoid arthritis (RA).PurposeOur purpose was to review the response to, and safety of, tocilizumab.Materials and methodsRetrospective and descriptive study...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have